Session information
Oral Session
[O-28] Oral Session 28
Fri. Jun 2, 2023 9:45 AM - 11:15 AM Room6 (幕張メッセ国際会議場 3F 302)
Chair:Melki Ronald (CEA-CNRS-University Paris Saclay, France)
Tadanori Hamano1,2, Miku Imai1, Ryota Yamamoto1, Hirohito Sasaki1, Kanaan Nicholas3, Shigeo Murayama4, Maho Morishima4, Hironobu Naiki5, Shu-hui Yen6, Koji Aoki7, Rei Asano1, Yuki Kitazaki1, Tomoihsa Yamaguchi1, Yoshinori Endo1, Soichi Enomoto1,2, Norimichi Shirafuji1,2, Kouji Hayashi1, Masamichi Ikawa1, Osamu Yamamura1, Yasunari Nakamoto8 (1.Departmento of Neurology, University of Fukui, Japan, 2.Department of Aging and Dementia (DAD), University of Fukui, Japan, 3.Michigan State University, USA, 4.Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospitaland Institute of Gerontology, Japan, 5.Department of Molecular Pathology, University of Fukui, Japan, 6.Department of Neuroscience, Mayo Clinic Jacksonville, USA, 7.Department of Pharmacology, University of Fukui, Japan, 8.Department of Gastroenterology, University of Fukui, Japan)
Keyoumu Nazere1,2, Tetsuya Takahashi3, Naoyuki Hara4, Kazuki Muguruma5, Masahiro Nakamori2, Yu Yamazaki2, Hiroyuki Morino1,2, Hirofumi Maruyama2 (1.Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Japan, 2.Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan, 3.Department of Rehabilitation, Faculty of Rehabilitation, Hiroshima International University, Japan, 4.Department of Neurology, Hiroshima Municipal Northern Medical Center Asa Municipal Hospital, Japan, 5.Department of Neurology, Hiroshima Municipal Rehabilitation Hospital, Japan)
Masaki Ohyagi1,2, Mana Iizuka-koga1, Minako Ito3, Akihiko Yoshimura1 (1.Department of Microbiology and Immunology, Keio University School of Medicine, Japan, 2.Department of Neurological Science, Tokyo Medical and Dental University, Japan, 3.Division of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University, Japan)
Yasuomi Ouchi1, Norihiro Harada2, Toshiharu Suzuki3 (1.Dept of Biofunctional Imaging, Hamamatsu University Sch Med, Japan, 2.CRL, Hamamatsu Photonics KK, Japan, 3.Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan)
[O-28-6] RGMa signaling as a novel therapeutic target against vascular and diabetes-related dementia
Takahide Itokazu1,2, Hiroki Uno2, Shinya Yamamoto2, Toshihide Yamashita1,2 (1.Neuro-Medical Science, Graduate School of Medicine, Osaka University, Japan, 2.Molecular Neuroscience, Graduate School of Medicine, Osaka University, Japan)